Key result
Immediate Impella 5.0 support or upgrading from 2.5 to 5.0 suggested improved 30-day survival compared to Impella 2.5 support alone in cardiogenic shock.
Why the study?
Does the Impella 5.0 device improve survival compared to the Impella 2.5 device in ST-elevation myocardial infarction patients with profound cardiogenic shock?
Observational (n=34)
No
Does the Impella 5.0 device improve survival compared to the Impella 2.5 device in ST-elevation myocardial infarction patients with profound cardiogenic shock?
In STEMI patients with profound cardiogenic shock, initial experience suggests immediate or upgraded use of the Impella 5.0 device may improve survival compared to the Impella 2.5 device alone.
Answers are grounded in this paper and cite their sources.
May support higher-flow Impella in profound shock; hypothesis-generating and should not change practice without randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Engström et al. (2011) conducted an observational in ST-elevation myocardial infarction with profound cardiogenic shock (n=34). Impella 5.0 vs. Impella 2.5 was evaluated on Survival at 30 days. Immediate Impella 5.0 support or upgrading from 2.5 to 5.0 suggested improved 30-day survival compared to Impella 2.5 support alone in cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: